ArticleMolecular oncology2022

Genome-wide aneuploidy detected by mFast-SeqS in circulating cell-free DNA is associated with poor response to pembrolizumab in patients with advanced urothelial cancer.

Pauline A J Mendelaar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.